Post-Procedure Analgesic Management
Copyright © 2023 Elsevier Inc. All rights reserved..
During the development of multimodal pain management protocols, practitioners need to consider the potential risks each treatment modality inherently carries in order to prevent or diminish harmful outcomes. As an example, the part dentists played in the early stages of the opioid epidemic in the United States of America should serve as a cautionary account. By understanding the roots of this crisis, as practitioners we are better equipped to implement the novel analgesic agents available today to optimize post-operative pain control while minimizing any risk of addiction and harm to our communities. It is therefore critical that our colleagues understand the variety of accessible options for pain management to assure that our profession is able to seek adequate and sustainable relief for our post-operative patients. This article will go in depth to explain the analgesic tools practitioners can implement for an effective low-risk protocol, including a combination of NSAIDS and acetaminophen approach, using long-acting local anesthetics such as Exparel, pregabalin, gabapentin, ketamine, dexmedetomidine, and corticosteroids, and enhanced recovery after surgery protocols.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 2023 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:68 |
---|---|
Enthalten in: |
Dental clinics of North America - 68(2023), 1 vom: 11. Jan., Seite 213-225 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Andre, Amanda [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 13.11.2023 Date Revised 24.11.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.cden.2023.07.003 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM364432942 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM364432942 | ||
003 | DE-627 | ||
005 | 20231226095424.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.cden.2023.07.003 |2 doi | |
028 | 5 | 2 | |a pubmed24n1214.xml |
035 | |a (DE-627)NLM364432942 | ||
035 | |a (NLM)37951635 | ||
035 | |a (PII)S0011-8532(23)00115-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Andre, Amanda |e verfasserin |4 aut | |
245 | 1 | 0 | |a Post-Procedure Analgesic Management |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 13.11.2023 | ||
500 | |a Date Revised 24.11.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 Elsevier Inc. All rights reserved. | ||
520 | |a During the development of multimodal pain management protocols, practitioners need to consider the potential risks each treatment modality inherently carries in order to prevent or diminish harmful outcomes. As an example, the part dentists played in the early stages of the opioid epidemic in the United States of America should serve as a cautionary account. By understanding the roots of this crisis, as practitioners we are better equipped to implement the novel analgesic agents available today to optimize post-operative pain control while minimizing any risk of addiction and harm to our communities. It is therefore critical that our colleagues understand the variety of accessible options for pain management to assure that our profession is able to seek adequate and sustainable relief for our post-operative patients. This article will go in depth to explain the analgesic tools practitioners can implement for an effective low-risk protocol, including a combination of NSAIDS and acetaminophen approach, using long-acting local anesthetics such as Exparel, pregabalin, gabapentin, ketamine, dexmedetomidine, and corticosteroids, and enhanced recovery after surgery protocols | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Dental post-operative pain management | |
650 | 4 | |a Dental post-procedure analgesia | |
650 | 4 | |a Liposomal local anesthetics | |
650 | 4 | |a Non-opioid analgesics | |
650 | 4 | |a Opioid alternatives | |
650 | 7 | |a Analgesics |2 NLM | |
650 | 7 | |a Anti-Inflammatory Agents, Non-Steroidal |2 NLM | |
650 | 7 | |a Acetaminophen |2 NLM | |
650 | 7 | |a 362O9ITL9D |2 NLM | |
650 | 7 | |a Analgesics, Opioid |2 NLM | |
700 | 1 | |a Benichou, Michael |e verfasserin |4 aut | |
700 | 1 | |a Dym, Harry |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Dental clinics of North America |d 1965 |g 68(2023), 1 vom: 11. Jan., Seite 213-225 |w (DE-627)NLM000030082 |x 1558-0512 |7 nnns |
773 | 1 | 8 | |g volume:68 |g year:2023 |g number:1 |g day:11 |g month:01 |g pages:213-225 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cden.2023.07.003 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 68 |j 2023 |e 1 |b 11 |c 01 |h 213-225 |